|
Wed, 01/15/2025 - 18:33 |
IVF pregnancies at greater risk of exposure to medicines that can harm fetus |
UWA |
|
Tue, 12/01/2020 - 17:54 |
New toolkit aims to improve global birth defects surveillance |
WHO |
|
Wed, 07/24/2019 - 17:30 |
A New Cellular Framework to Study Causes of Birth Defects |
Gladstone Institutes |
|
Thu, 04/18/2019 - 02:06 |
Research Brief: Risk of congenital Zika syndrome greater than previously thought |
UniversityofMin... |
|
Fri, 04/12/2019 - 21:18 |
Higher Rate of Minor Birth Defects in Children of Women Gulf War Veterans |
ACOEM |
|
Mon, 12/24/2018 - 05:29 |
Genetic Disease Screening Program |
CDPH |
|
Wed, 12/19/2018 - 03:32 |
How children, teens die in America: Study reveals widespread, persistent role of firearms |
University of M... |
|
Thu, 12/13/2018 - 10:13 |
Drug Targets for Ebola, Dengue, and Zika Viruses Found in Lab Study |
Gladstone Institutes |
|
Tue, 12/11/2018 - 07:55 |
Amicus Therapeutics Awarded United Kingdom Prix Galien Medal for Galafold (Migalastat) |
amicus |
|
Wed, 12/05/2018 - 12:41 |
Rift Valley Fever is Catastrophic to Developing Fetuses |
UniversityofPit... |
|
Tue, 12/04/2018 - 23:19 |
Genentechs Kadcyla Cut the Risk of Disease Recurring by Half Compared to Herceptin in People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment |
Genentech |
|
Sun, 12/02/2018 - 10:54 |
Celgene Corporation Announces Results of AUGMENT Evaluating REVLIMID In Combination with Rituximab (R) In Patients with Relapsed/Refractory Indolent Lymphoma At ASH 2018 |
BMS |
|
Thu, 11/29/2018 - 06:57 |
Sanofi builds focus on rare blood disorders and cancers |
Genzyme |
|
Wed, 11/14/2018 - 18:55 |
After 20 years, stem cells mean business in Wisconsin |
University of W... |
|
Thu, 11/08/2018 - 01:34 |
DHHS Releases Analysis of Selected Birth Defects in Five Southeastern North Carolina Counties |
NC DHHS |
|
Tue, 11/06/2018 - 02:04 |
U.S. Food and Drug Administration Approves Empliciti (elotuzumab) Plus Pomalidomide and Dexamethasone, a New Immunotherapy Combination for Certain Patients with Relapsed or Refractory Multiple Myeloma |
MMRF |
|
Fri, 11/02/2018 - 07:47 |
Thalidomide reveals path for targeting "undruggable" transcription factors for cancer treatment |
Broad Institute |
|
Tue, 10/30/2018 - 14:46 |
ViiV Healthcare reports positive 48-week results for second phase III study for novel, long-acting, injectable HIV-treatment regimen |
GlaxoSmithKline |
|
Mon, 10/29/2018 - 09:59 |
Mount Sinai Recognized for Excellence in Mitochondrial Care |
Mount Sinai |
|
Tue, 10/23/2018 - 11:09 |
REVLIMID (lenalidomide) Demonstrated a Significant Improvement in Progression-Free Survival (PFS) Compared with Observation in a Randomized Study in Patients with Smoldering Multiple Myeloma |
BMS |
|
Sun, 10/14/2018 - 17:56 |
Genentechs Kadcyla Reduced the Risk of Disease Recurring in People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment |
Genentech |
|
Tue, 09/25/2018 - 07:30 |
Disinfectant Cleaners Linked to Weight Gain in Infants and Toddlers |
Environmental W... |
|
Mon, 09/24/2018 - 09:45 |
DHSS, Fetal Alcohol Task Force and Brandywine Counseling & Community Services Remind Pregnant Women Not to Drink During Pregnancy |
Delaware State ... |
|
Wed, 09/19/2018 - 21:47 |
Scientists Grow Human Esophagus in Lab |
Cincinnati Childrens |
|
Wed, 09/12/2018 - 21:27 |
Signaling pathway frequently altered in cancer controls normal kidney development |
HelsinkiUniv |
